Hanall to launch Normix, a broad antibiotic.

Hanall announced that Normix (Rifaximin) started to market from March 6 under the distribution agreement with Alfa Wassermann, an Italian pharmaceutical company dated on March 2. Normix tablet is an antibiotic specialized in the GI infections with which its pharmacological action limited only on the GI tract without systemic absorption after administration, nor interfering the intestinal normal...